NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 104 filers reported holding NURIX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,424 | -36.8% | 24,227 | -19.6% | 0.40% | -14.4% |
| Q2 2023 | $301,119 | +3.0% | 30,142 | -8.5% | 0.47% | +9.1% |
| Q1 2023 | $292,454 | -27.9% | 32,934 | -10.8% | 0.43% | -17.4% |
| Q4 2022 | $405,469 | -33.6% | 36,928 | -21.3% | 0.52% | -13.8% |
| Q3 2022 | $611,000 | -2.1% | 46,915 | -4.7% | 0.60% | +4.5% |
| Q2 2022 | $624,000 | -6.2% | 49,217 | +3.7% | 0.57% | +59.0% |
| Q1 2022 | $665,000 | -51.4% | 47,464 | +0.4% | 0.36% | -24.0% |
| Q4 2021 | $1,369,000 | +13.6% | 47,292 | +17.6% | 0.48% | +17.9% |
| Q3 2021 | $1,205,000 | +92.5% | 40,212 | +70.3% | 0.40% | +75.2% |
| Q2 2021 | $626,000 | – | 23,611 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 561,574 | $16,825,000 | 24.93% |
| Ponoi Management, LLC | 561,573 | $16,825,000 | 14.94% |
| TRV GP III, LLC | 2,422,549 | $72,580,000 | 13.78% |
| Foresite Capital Management IV, LLC | 1,205,798 | $36,126,000 | 5.32% |
| Foresite Capital Management V, LLC | 451,522 | $13,528,000 | 4.20% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,489,000 | 2.62% |
| DAFNA Capital Management LLC | 306,320 | $9,177,000 | 2.44% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $38,478,000 | 2.39% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 571,212 | $17,113,000 | 2.02% |
| Redmile Group, LLC | 3,093,077 | $92,669,000 | 1.62% |